Fibromyalgia Syndrome: Oxford Rheumatology Library
Autor Ernest Choyen Limba Engleză Paperback – 25 mar 2009
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (2) | 149.75 lei 42-48 zile | |
OUP OXFORD – 23 sep 2015 | 209.62 lei 3-5 săpt. | |
Oxford University Press – 25 mar 2009 | 149.75 lei 42-48 zile |
Preț: 149.75 lei
Preț vechi: 170.52 lei
-12% Nou
Puncte Express: 225
Preț estimativ în valută:
28.66€ • 30.24$ • 23.88£
28.66€ • 30.24$ • 23.88£
Carte tipărită la comandă
Livrare economică 02-08 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780199547517
ISBN-10: 0199547513
Pagini: 96
Ilustrații: Various line drawings
Dimensiuni: 99 x 180 x 5 mm
Greutate: 0.09 kg
Editura: Oxford University Press
Colecția OUP Oxford
Seria Oxford Rheumatology Library
Locul publicării:Oxford, United Kingdom
ISBN-10: 0199547513
Pagini: 96
Ilustrații: Various line drawings
Dimensiuni: 99 x 180 x 5 mm
Greutate: 0.09 kg
Editura: Oxford University Press
Colecția OUP Oxford
Seria Oxford Rheumatology Library
Locul publicării:Oxford, United Kingdom
Recenzii
This pocket book represents a handy and practical tool for rheumatologists and general practitioners aimed at facilitating the diagnosis and the management of fibromyalgia syndrome in daily practice.
This is a most helpful and comprehensive little book.
This is a most helpful and comprehensive little book.
Notă biografică
Ernest Choy is Professor of Rheumatology at the Cardiff Institute of Infection & Immunity. He has a major research interest in experimental medicine and clinical trial design in rheumatic diseases, and has conducted many proof-of-concept, first in human clinical trials in inflammatory arthritis. Professor Choy has served as Chief Investigators of many clinical trials which have been funded by Medical Research Council, Arthritis Research UK, NIHR Health Technology Assessment, Arthritis Research UK and pharmaceutical companies. He is also interested in improving the assessment of disease by developing better outcome measures. He has served as chair to a number of working groups in the Outcome Measures for Rheumatology organisation.